Curaleaf Holdings Inc. (CURA : TSX)
Common Stock
Follow CURA
CURA
Curaleaf Holdings Inc.
Performance
1 Day
+3.21%
1 Week
-8.75%
1 Month
+4.52%
YTD
+7.73%
The Saturday TSX Wrap · free, every saturday morning. The week on the TSX, in five minutes.
Key Statistics
Market Cap
$2.97B
52W High
$20.93
52W Low
$7.77
P/E Ratio
-
50 Day MA
$13.37
200 Day MA
$12.52
Beta
1.76
Dividend Yield
-
WA Score
How CURA stacks up against 944 Canadian stocks
out of 99
- Value49
Not profitable over the last 12 months.
- Quality
- Momentum53
7.7% this year, below its 200-day average, 29% of the way up its 52-week range.
- Analysts
- Insiders
Each factor is a percentile against Canadian common stocks worth $50M or more on the TSX and TSX Venture (90 = better than 90% of them). Built from exchange prices, company financials, analyst targets and SEDI insider filings. A data summary, not advice. How it works · Top-scoring stocks
Performance history
CURA returns since 2016
Curaleaf Holdings Inc. has returned +8.3% a year over the last 10 years, with 3 up years out of 8 full calendar years. Its deepest fall was −94.5% (Apr 2021 to Apr 2025).
1 year / yr
+36.3%
3 years / yr
−6.4%
5 years / yr
−20.9%
10 years / yr
+8.3%
Calendar-year returns
- 2016*−37.5%
- 2017−20.0%
- 2019−21.3%
- 2020+86.3%
- 2021+567.3%
- 2022−48.4%
- 2023−5.5%
- 2024−59.3%
- 2025+52.2%
- 2026*+13.1%
* Partial year (first year of data, or year to date).
$10,000 invested in CURA
- 1 year ago$13,628
- 5 years ago$3,090
- 10 years ago$22,236
- Best year
- 2021: +567.3%
- Worst year
- 2024: −59.3%
- All-time high in our data
- $56 on Apr 7, 2021 · now −79.3%
Total-return basis using adjusted daily closes from the Toronto Stock Exchange and TSX Venture (dividends and splits folded in), Jan 2016 to Nov 2026. Past returns do not predict future ones.
Earnings
CURA earnings history
Curaleaf Holdings Inc. beat the EPS estimate in 3 of its last 4 reported quarters.
Next report
Feb 25, 2027 · after close
EPS estimate −$0.15
| Quarter ending | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Sep 30, 2026 | Nov 3, 2026 | −$0.17 | −$0.15 | −15.3% |
| Jun 30, 2026 | Aug 5, 2026 | $0.07 | −$0.24 | +129.2% |
| Mar 31, 2026 | May 4, 2026 | $0.29 | −$0.27 | +207.4% |
| Dec 31, 2025 | Feb 26, 2026 | −$0.05 | −$0.09 | +44.4% |
| Sep 30, 2025 | Nov 4, 2025 | −$0.19 | −$0.24 | +20.8% |
| Jun 30, 2025 | Aug 6, 2025 | −$0.19 | −$0.21 | +9.5% |
| Mar 31, 2025 | May 8, 2025 | −$0.23 | −$0.21 | −9.5% |
| Dec 31, 2024 | Mar 4, 2025 | $0.02 | −$0.08 | +125.0% |
EPS as reported vs consensus estimate. TSX earnings calendar →
Awesome Portfolio™
Looking past CURA? Our 10 best Canadian stocks, in one list.
14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.
Curaleaf Holdings Inc. insider transactions
Open-market and private equity trades (last 12 months volume). Derivatives and opening balances excluded.
Recent transactions
| Date | Side | Name | Shares | Price |
|---|---|---|---|---|
| Sep 09, 26 | Buy | Clateman, Peter Laurence Individual · CA$32,861 | 22,223 | CA$1.48 |
| Sep 09, 26 | Sell | Clateman, Peter Laurence Individual · CA$101,997 | 10,000 | CA$10.20 |
| Sep 09, 26 | Sell | Clateman, Peter Laurence Individual · CA$33,677 | 3,334 | CA$10.10 |
| Sep 03, 26 | Sell | Johansson, Karl Individual · CA$373,940 | 39,000 | CA$9.59 |
| Aug 26, 26 | Sell | Clateman, Peter Laurence Individual · CA$94,339 | 10,000 | CA$9.43 |
| Aug 26, 26 | Sell | Clateman, Peter Laurence Individual · CA$31,440 | 3,334 | CA$9.43 |
| Aug 26, 26 | Buy | Clateman, Peter Laurence Individual · CA$32,861 | 22,223 | CA$1.48 |
| Aug 14, 26 | Sell | Clateman, Peter Laurence Individual · CA$30,576 | 3,334 | CA$9.17 |
| Aug 14, 26 | Buy | Clateman, Peter Laurence Individual · CA$32,861 | 22,223 | CA$1.48 |
| Aug 14, 26 | Sell | Clateman, Peter Laurence Individual · CA$92,197 | 10,000 | CA$9.22 |
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 11/16/2026 | $11.20 | $11.67 | $10.90 | $11.57 | $11.57 | 262,452 |
| 11/13/2026 | $11.79 | $11.79 | $11.08 | $11.21 | $11.21 | 239,431 |
| 11/12/2026 | $12.48 | $12.48 | $11.77 | $11.85 | $11.85 | 294,154 |
| 11/11/2026 | $12.76 | $12.91 | $12.22 | $12.69 | $12.69 | 210,676 |
| 11/10/2026 | $12.52 | $12.92 | $12.43 | $12.70 | $12.70 | 296,615 |
| 11/9/2026 | $13.27 | $13.27 | $12.57 | $12.68 | $12.68 | 259,839 |
| 11/6/2026 | $13.28 | $13.71 | $13.18 | $13.23 | $13.23 | 337,163 |
| 11/5/2026 | $13.35 | $13.50 | $12.87 | $13.22 | $13.22 | 514,356 |
| 11/4/2026 | $14.01 | $14.28 | $12.90 | $13.40 | $13.40 | 515,852 |
| 11/3/2026 | $13.03 | $14.55 | $13.03 | $14.23 | $14.23 | 674,576 |
Analyst Price Targets
Based on analyst covering CURA · as of Nov 16, 2026
Wall Street analysts forecast CURA stock price to rise 71.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$19.79
+71.0% Upside
Previously C$19.70 on Nov 11, 2026
Current Price
C$11.57
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CURA's historical volatility
30-Day Vol
67.6%
Annualized
90-Day Vol
60.0%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$9.68
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$10.90 | C$8.63 – C$13.76 |
| 60 trading days | C$10.27 | C$7.39 – C$14.28 |
| 90 trading days | C$9.68 | C$6.46 – C$14.49 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Curaleaf Holdings Inc.
Curaleaf Holdings, Inc. engages in the retail and wholesale of cannabis products in the United States and internationally. The company operates licensed cultivation; and pharma-grade cannabis processing and manufacturing facilities. It also supplies cannabis on a wholesale basis to Australia, New Zealand, the United Kingdom and various European countries, including Germany, Italy, Poland, the Czech Republic, Switzerland, Sweden and Norway. In addition, the company operates a medical cannabis clinic and holds a pharmacy license. It serves the medical and adult-use cannabis markets through retail and wholesale channels. The company is based in Stamford, Connecticut.
Financials
- Revenue (TTM)
- $1.35B
- EBITDA
- $208.46M
- Profit Margin
- -0.76%
- ROE (TTM)
- -0.50%
- EPS (Diluted)
- -0.07
- Book Value
- 4.49
🔄 Recent Splits
1-for-3
Jun 5, 2026
Free newsletter
The Saturday TSX Wrap
The week on the TSX, in five minutes
- The biggest gainers and losers, and why they moved
- Sector and momentum moves at a glance
- The Canadian market stories you missed
Explore More
Common Questions About CURA
Market movers
Recent TSX movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| HWO | High Arctic Energy Services Inc. | $1.74 | +29.85% |
| AAV | Advantage Oil & Gas Ltd. | $13.45 | +23.74% |
| LUC | Lucara Diamond Corp | $0.13 | +13.64% |
| T | Telus Corp | $13.70 | +12.85% |
| FRX | Fennec Pharmaceuticals Inc | $18.35 | +10.81% |
| KEL | Kelt Exploration Ltd. | $12.72 | +10.70% |
| NVO | Novo Resources Corp | $0.07 | +8.33% |
| ELO | Eloro Resources Ltd. | $1.23 | +7.89% |
Free with a Wealth Awesome account
Keep analysing CURA, free
- Every WA Score, ranking and table
- Insider track records and SEDI filings
- Earnings history and analyst targets for every stock
Email only, no password, no card. Already a member? Use the same button to sign in.